Fig. 5From: Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidatesReverse phase HPLC analysis of recombinant Pfs25 proteins. Reverse phase HPLC of a Pichia derived Pfs25 and b Baculovirus derived Pfs25Back to article page